ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in ENvue Medical, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +4 vs. Q2 2021
- Shares held
- 1.26M
- +136.8K (+12.2%) vs. Q2 2021
- Total value
- $2.60M
- +$1.64M (+172.0%) vs. Q2 2021
- New holders
- 11
- 6 more added
- Sold out
- 7
- 1 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FEED on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $149.2K |
| Q1 2026 | 13 | $179.2K |
| Q4 2025 | 6 | $42.5K |
| Q3 2025 | 6 | $9.50K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 9 | $215.3K |
| Q3 2024 | 9 | $251.5K |
| Q2 2024 | 8 | $163.3K |
| Q1 2024 | 10 | $327.2K |
| Q4 2023 | 11 | $123.0K |
| Q3 2023 | 13 | $242.1K |
| Q2 2023 | 9 | $142.1K |
| Q1 2023 | 10 | $203.6K |
| Q4 2022 | 18 | $593.0K |
| Q3 2022 | 15 | $679.0K |
| Q2 2022 | 13 | $906.0K |
| Q1 2022 | 19 | $2.12M |
| Q4 2021 | 20 | $1.72M |
| Q3 2021 | 21 | $2.60M |
| Q2 2021 | 17 | $954.1K |
| Q1 2021 | 14 | $1.17M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding ENvue Medical, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 322,919 | $665.0K | 0.00% | +14,000+4.5% | Added |
| Geode Capital Management, LLC | 200,752 | $413.0K | 0.00% | +63,868+46.7% | Added |
| Two Sigma Investments, LP | 161,771 | $333.0K | 0.00% | +161,771 | New |
| Amtrust Financial Services, Inc. | 146,148 | $301.0K | 0.29% | 00.0% | Unchanged |
| State Street Corp | 94,890 | $195.0K | 0.00% | +53,300+128.2% | Added |
| Northern Trust Corp | 46,869 | $97.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,824 | $84.0K | 0.00% | −59,024−59.1% | Reduced |
| Bridgeway Capital Management, LLC | 37,413 | $77.0K | 0.00% | +37,413 | New |
| Bank of New York Mellon Corp | 33,330 | $69.0K | 0.00% | +33,330 | New |
| XTX Topco Ltd | 30,847 | $64.0K | 0.02% | +30,847 | New |
| Squarepoint Ops LLC | 27,690 | $57.0K | 0.00% | +27,690 | New |
| Bank of America Corp | 25,018 | $52.0K | 0.00% | +25,009+277,877.8% | Added |
| Morgan Stanley | 19,576 | $40.0K | 0.00% | +19,576 | New |
| Steel Peak Wealth Management LLC | 15,515 | $32.0K | 0.00% | +15,515 | New |
| Jane Street Group, LLC | 15,094 | $31.0K | 0.00% | +15,094 | New |
| Sabby Management, LLC | 10,000 | $21.0K | 0.00% | +10,000 | New |
| Private Wealth Strategies, L.L.C. | 10,000 | $21.0K | 0.01% | +10,000 | New |
| Psagot Investment House Ltd. | 9,720 | $20.0K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 9,720 | $20.0K | 0.00% | +9,720 | New |
| Tower Research Capital LLC (TRC) | 1,678 | $3.00K | 0.00% | +1,587+1,744.0% | Added |
| Wells Fargo & Company | 148 | $0 | 0.00% | +8+5.7% | Added |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −92,552−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −85,213−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −65,046−100.0% | Sold out |
| Plotkin Financial Advisors, LLC | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −26,248−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |